|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Isolates with low-level vancomycin resistance associated with persistent methicillin- resistant Staphylococcus aureus bacteremia显示文摘 | Howden BP Johnson PD Ward PB | 2006 | Antimicrob Agents Chemother2006，50，： | 1 |
| 2 | Vancomycin in the treatment of methicillin- resistant Staphylococcus aureus - a clinician's guide to the science informing current practice显示文摘 | Lee JY Howden BP | 2015 | Expert Rev Anti Infect Therapy2015，13，7： | 1 |
| 3 | Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus 显示文摘 | Howden BP Grayson ML | 2006 | Clin Infect Dis2006，42，3： | 1 |
| 4 | Good clinical outcomes but highrates of adverse reactions during linezolidtherapy for serious infections:A proposed protocol for monitoring therapy in complex patients显示文摘 | Bishop E Melvani S Howden BP etal | 2006 | Antimicrob Agents Chemother2006，50，： | 1 |
| 5 | In vitro phar macodynamics of colistin against muhidrug-resistant Klebslella pneumonlae显示文摘 | Poudyal A Howden BP Bell JM | 2008 | J Antimicrob Chemoth- er2008，62，6： | 1 |
| 6 | Cenomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus显示文摘 | Howden BP Stinear TP Allen DL | 2008 | Antimicrob Agents Chemother2008，2，10： | 1 |
| 7 | In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumonia显示文摘 | Poudyal A Howden BP Bell JM | 2008 | J Antimicrob Chemother2008，62，6： | 1 |
| 8 | Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients 显示文摘 | BISHOP E MELVANI S HOWDEN BP | 2006 | Antimicrob Agents Chemother2006，50，4： | 1 |
| 9 | Reduced vancomycin susceptibility in Staphylococcus aureus,including vancomycin-in- termediate and heterogeneous vancomycin-intermediate strains:resistance mechanisms,laboratory detection,and clinical implica- tions显示文摘 | Howden BP Davies JK Johnson PD | 2010 | Clin Microbiol Rev2010，23，1： | 1 |
| 10 | Treatment out comes for serious infections caused by n, ethicillin resistant Staph ylococcus aureus with reduced vancomycin susceptihility显示文摘 | Howden BP Ward PB Charles PGP | 2004 | Clin Infect Dis2004，38，： | 1 |
| 11 | Reduced vancomy- cin susceptibility in Staphylococcus aureus,ineluding vancomy- cin- intermediate and heterogeneous vancomyein-intermediate strains: resistance mechanisms, laboratory detection, and clini- cal implications显示文摘 | Howden BP Davies JK Johnson PD | 2010 | Clin Microbiol Rev2010，23，： | 1 |
| 12 | Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin- intermediate and heterogeneous vaneomycin-intermediate strains : resistance mechanisms, laboratory detection, and clinical implications 显示文摘 | Howden BP Davies JK Johnson PDR | 2010 | Clinical Microbiology Reviews2010，23，1： | 1 |
| 13 | The importance of regulatory RNAs in Staphylococcus aureus显示文摘 | Tomasini A Francois P Howden BP | 2014 | Infect Ge- net Evol2014，21，： | 1 |
| 14 | Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin- susceptible entemcoccal bacteraemia 显示文摘 | Cheah AL Peel T Howden BP | 2014 | BMC Infect Dis2014，14，： | 1 |
| 15 | Reduced vancomycin suscep- tibility in Staphylococcus aureus, including vancomycin - intermediate and heterogeneous vancomycin - intermediate strains: Resistance me- chanisms, laboratory detection, and clinical implications 显示文摘 | Howden BP Davies JK Johnson PD | 2010 | Clin Mi- crobiol Rev2010，23，1： | 1 |
| 16 | Good clinical out- comes but high rates of adverse reactions during linezolid therapy for serious infections:a proposed protocol for monito- ring therapy in complex patients显示文摘 | Bishop E Melvani S Howden BP | 2006 | Antlmicrob Agents Che- mother2006，50，4： | 1 |
| 17 | Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility显示文摘 | Howden BP Ward PB Charles PG | | 0，，： | 1 |
| 18 | Cytomegatovirus voral,load momtofing after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxis显示文摘 | Howden BP Michaelides A Spelman DW | 2003 | Bone Marrow Transplant2003，32，： | 1 |
| 19 | Reduced vaneomycin susceptibility in Staphylococcus aureus,including vancomyein-in- termediate and heterogeneous vancomyein-intermediate strains: resistance mechanisms, laboratory detection, and clinical impliea- tions显示文摘 | Howden BP Davies JK Johnson PD | 2010 | Clin Mierobiol Rev2010，23，1： | 1 |
| 20 | Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus(MRSA)and vancomycinsusceptible MRSA显示文摘 | Home KC Howden BP Grabsch EA | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员